15 May 2025
SC Launch Inc., the investment affiliate of the South Carolina Research Authority, has invested $250,000 in NeuroQuest. The Charleston-based company is developing NeuroScreen® to provide an accurate and affordable blood test for early screening and monitoring of asymptomatic Alzheimer’s disease.
NeuroQuest became a SCRA Member Company and SC Launch Inc. Portfolio Company when it received its first investments totaling $550,000.
According to the Alzheimer’s Association, nearly 7 million Americans are living with Alzheimer’s disease, and by 2050, this number is projected to rise to almost 13 million.
NeuroQuest presented research demonstrating the efficacy of NeuroScreen® at the most recent Alzheimer’s Association International Conference, where the leading global medical and scientific dementia research community meets to learn about the latest research, products, and solutions available in treating Alzheimer’s and related dementias. NeuroQuest Chairman of the Board Dr. Jacobo Mintzer explained that NeuroScreen® introduces a breakthrough in the evolution of Alzheimer’s diagnostics.
This news was published: South Carolina Research Authority
These devastating statistics are why we’re so supportive of NeuroQuest’s mission. NeuroQuest’s team is comprised of medical experts and business professionals from around the world with extensive experience in innovation, development, and clinical research, and they have the experience to lead in this ground-breaking way.
Lee MacIlwinen, SC Launch Program Director
The teams at SCRA and SC Launch Inc. have been with us from the beginning, and we really appreciate their advice and funding. Our solution uniquely identifies asymptomatic individuals as early and effectively as possible. Our test delivers benefits for not only patients and their families, but also for healthcare providers and treatment prescribers.
Jason Maxwell, NeuroQuest CEO
We’re excited to continue supporting such an important diagnostic solution. The team at NeuroQuest will be finalizing its pre-clinical product development with this investment. This is another important step to earlier and better detection for Alzheimer’s. We look forward to their continued success.
Matt Bell, SC Launch Inc. Executive Director
See More News
FruitSpec raises $5 million
FruitSpec’s Yield Management Platform provides digital visibility of fruit yield data to entire supply-chain production units
Phytolon secures $4.1 million in funding
Funding for fermentation-based technology for the production of food colors
